BioAge Labs (BIOA) Depreciation & Amortization (CF) (2023 - 2026)
BioAge Labs (BIOA) reported Depreciation & Amortization (CF) of $100000.0 for Q1 2026, little changed on a YoY basis from $100000.0 in Q1 2025, and little changed sequentially from $100000.0 in Q4 2025.
BioAge Labs (BIOA) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $400000.0 (changed 0.0% YoY), and the FY2025 full-year result was $200000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) held at $100000.0 in Q1 2026, from $100000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $100000.0 in Q3 2023 to a low of $100000.0 in Q3 2023.
- A 4-year average of $100000.0 and a median of $100000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
- Tracing BIOA's Depreciation & Amortization (CF) over 4 years: stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
- Business Quant data shows BIOA's Depreciation & Amortization (CF) at $100000.0 in Q1 2026, $100000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |